Cap Raise shouldn't be an option if they have a successful clinical trial. They will be bought out well before then, and having natural medicinal properties with a unique physiology being sold worldwide, it won't be cheap.
Ann: NTI164 Clinical Program Update, page-12
Add NTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.5¢ |
Change
-0.006(8.45%) |
Mkt cap ! $66.13M | |||
| Open | High | Low | Value | Volume |
| 7.1¢ | 7.2¢ | 6.4¢ | $223.5K | 3.296M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4000 | 6.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.9¢ | 135000 | 1 |
View Market Depth
| Last trade - 15.55pm 03/06/2024 (20 minute delay) ? |
|
|||||
|
Last
6.6¢ |
Change
-0.006 ( 8.33 %) |
||||
| Open | High | Low | Volume | ||
| 7.0¢ | 7.0¢ | 6.5¢ | 466888 | ||
| Last updated 15.21pm 03/06/2024 ? | |||||
| NTI (ASX) Chart |